Medicinal Chemistry Barbara Slusher, Ph.D, Brain Science Institute, Johns Hopkins University Gordon Bundy, Ph.D., Consultant Animal Models of Disease California State University, Northridge University of North Texas, Health Science Center Ischemia University of Alaska, Fairbanks – Dr. Kelly Drew
The directors are Judith Kelleher-Andersson, Kathleen L. Mattis, Robin Oegerle, Maurice Gagnon, and Kenneth Narducy. The scientific advisory board includes Scott Turner and David A. Greenburg.
Judith Kelleher-Andersson has over 20 years of experience developing small-molecule central nervous system therapeutics and previously led drug development and research at Neuralstem, Inc., Centaur Pharmaceuticals, and Cortex Pharmaceuticals, Inc.
Judith Kelleher-Andersson, Ph.D., is founder, president, and CEO. Judith Kelleher-Andersson has worked in neuroscience for over 20 years as a graduate student and post-graduate fellow.
Society for Neuroscience (SFN) Women in Bio (WIB) American Association of Pharmaceutical Scientists (AAPS) The Tech Council of Maryland (TCM) The Wharton Club of DC